InsiderTrades

Form 4 for GPGI GPGI, Inc.

Accepted 2021-12-29 00:00:00 ET · period of report 2021-12-27 · accession 0001104659-21-154396 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-12-29 2021-12-27 GPGI Roman DBDR Tech Sponsor LLC 10% M - OptEx $0.00 +5.79M 5.79M New $0
D 2021-12-29 2021-12-27 GPGI Roman DBDR Tech Sponsor LLC 10% M - OptEx — -5.79M 0 -100% —
D 2021-12-29 2021-12-27 GPGI Roman DBDR Tech Sponsor LLC 10% A - Grant — +10.84M 10.84M New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-12-27 M A 5,789,000 $0.00 5,789,000 D — — (F2) Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the shares of Class A common stock held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
2 Derivative Class B Common Stock 2021-12-27 M D 5,789,000 — 0 D — · — to — 5,789,000 Class A Common Stock (F1) On December 27, 2021, Roman DBDR Tech Acquisition Corp. closed the previously announced business combination with CompoSecure Holdings, L.L.C. (the "Business Combination") pursuant to which CompoSecure, Inc. became a publicly-traded company (the "Company"). As a result of the Business Combination, each outstanding share of Class B Common Stock converted automatically on a one-for-one basis into shares of Class A Common Stock. (F2) Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the shares of Class A common stock held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
3 Derivative Warrants 2021-12-27 A A 10,837,400 — 10,837,400 D $11.50 · 2022-01-26 to 2026-12-27 10,837,400 Class A Common Stock (F3) Pursuant to the terms of the Company's warrants to purchase shares of Class A Common Stock, upon completion of the Business Combination, the warrants became exercisable beginning 30 days thereafter. (F4) Dr. Donald G. Basile, Chairman and Co-Chief Executive Officer of the registrant and Dixon Doll, Jr., the registrant's Co-Chief Executive Officer, are the managing members of the reporting person and have voting and investment discretion with respect to the securities held by the reporting person. As such, Messrs. Basile and Doll may be deemed to share beneficial ownership of the warrants held directly by the reporting person. Each of Messrs. Basile and Doll disclaim any beneficial ownership of the warrants other than to the extent of any pecuniary interest they may have therein, directly or indirectly.